Lodz, Poland

Jacek Chrzanowski

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Molecure S.a., Oncoarendi Therapeutics S.a.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacek Chrzanowski. Retrieved from https://idiyas.com/inventor/jacek-chrzanowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.7

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jacek Chrzanowski: Innovator in Pharmaceutical Compositions

Introduction

Jacek Chrzanowski is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions aimed at treating diseases associated with arginase activity.

Latest Patents

Jacek holds 1 patent for his work on dipeptide piperidine derivatives. This patent encompasses pharmaceutical compositions, methods of preparing these compositions, and their applications in treating or preventing conditions linked to arginase activity.

Career Highlights

Currently, Jacek is associated with Oncoarendi Therapeutics S.A., where he continues to advance his research and development efforts in the pharmaceutical sector. His work is pivotal in creating effective treatments that address critical health issues.

Collaborations

Jacek collaborates with esteemed colleagues, including Roman Blaszczyk and Anna Gzik, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jacek Chrzanowski's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work not only advances scientific knowledge but also has the potential to improve patient outcomes significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…